Association of Bone Marrow Sphingosine 1-phosphate Levels with Osteoporotic Hip Fractures
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Sphingosine 1-phosphate (S1P) has been discovered to be a critical regu-lator of bone metabolism. Very recently, we found that higher circulating S1P levels were associated with higher rate of prevalent osteoporotic fracture in human. Methods: This was a cross-sectional study of 16 patients who underwent hip replacement surgeries. Bone marrow fluids were obtained during hip surgeries, and the S1P levels were mea-sured using a competitive enzyme-linked immunosorbent assay (ELISA) assay. Bone mineral densities (BMDs) at various skeletal sites were obtained using dual energy X-ray absorptiometry. Results: Among 16 patients, 4 patients were undergone operations due to hip fractures, and the others were done by any other causes. Bone marrow S1P levels were significantly lower in patients with hip fractures than in those without, before and after adjusting for confounding factors (P=0.047 and 0.025, respectively). We failed to demonstrate significant associations between bone marrow S1P levels and any BMD values (γ=0.026-0.482, P=0.171-0.944). Conclusions: In conjunction with our previous findings, these suggest that the effects of gradient between peripheral blood and bone marrow, but not S1P itself, may be the most critical on bone metabolism.
Abstract
Background: Sphingosine 1-phosphate (S1P) has been discovered to be a critical regu-lator of bone metabolism. Very recently, we found that higher circulating S1P levels were associated with higher rate of prevalent osteoporotic fracture in human. Methods: This was a cross-sectional study of 16 patients who underwent hip replacement surgeries. Bone marrow fluids were obtained during hip surgeries, and the S1P levels were mea-sured using a competitive enzyme-linked immunosorbent assay (ELISA) assay. Bone mineral densities (BMDs) at various skeletal sites were obtained using dual energy X-ray absorptiometry. Results: Among 16 patients, 4 patients were undergone operations due to hip fractures, and the others were done by any other causes. Bone marrow S1P levels were significantly lower in patients with hip fractures than in those without, before and after adjusting for confounding factors (P=0.047 and 0.025, respectively). We failed to demonstrate significant associations between bone marrow S1P levels and any BMD values (γ=0.026-0.482, P=0.171-0.944). Conclusions: In conjunction with our previous findings, these suggest that the effects of gradient between peripheral blood and bone marrow, but not S1P itself, may be the most critical on bone metabolism.
참고문헌 (15)
- Rosen H, "Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network", Nat Rev Immunol, 5, pp.560~570 (2005)
- Grey A, "Osteoblastic cells express phospholipid receptors and phosphatases and proliferate in response to sphingosine-1-phosphate", Calcif Tissue Int, 74, pp.542~550 (2004)
- Pederson L, "Regulation of bone formation by osteoclasts involves Wnt", BMP signaling and the chemokine sphingosine-1-phosphate, 2008, pp.105, 20764~20769
- Roelofsen T, "Sphingosine-1-phosphate acts as a developmental stage specific inhibitor of platelet-derived growth factor-induced chemotaxis of osteoblasts", J Cell Biochem, 105, pp.1128~1138 (2008)
- Ryu J, "Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling", EMBO J, 25, pp.5840~5851 (2006)
- Peest U, "S1P-lyase independent clearance of extracellular sphingosine 1-phosphate after dephosphorylation and cellular uptake", J Cell Biochem, 104, pp.756~772 (2008)
- Zhao Y, "Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1", J Biol Chem, 282, pp.14165~14177 (2007)
- Maeda Y, "Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow", Int Immunol, 22, pp.515~525 (2010)
- Ishii M, "Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis", Nature, 458, pp.524~528 (2009)
- Ishii M, "Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo", J Exp Med, 207, pp.2793~2798 (2010)
- Ishii M, "Sphingosine-1-phosphate signaling controlling osteoclasts and bone homeostasis", Biochim Biophys Acta, 1831, pp.223~227 (2013)
- Taeko Ishii, "The Role of Sphingosine 1-Phosphate in Migration of Osteoclast Precursors; an Application of Intravital Two-Photon Microscopy", Molecules and Cells, 31(5), pp.399~403 (2011), 한국분자세포생물학회
- Lee SH, "Higher circulating sphingosine 1-phosphate levels are associated with lower bone mineral density and higher bone resorption marker in humans", J Clin Endocrinol Metab, 97, pp.E1421~E1428 (2012)
- Kim BJ, "Plasma sphingosine 1-phosphate levels and the risk of vertebral fracture in postmenopausal women", J Clin Endocrinol Metab, 97, pp.3807~3814 (2012)
- Cockcroft DW, "Prediction of creatinine clearance from serum creatinine", Nephron, 16, pp.31~41 (1976)